12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 137.1% to $3.17 during Tuesday’s regular session. Trading volume…
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday’s regular session. The current volume of 532.2K…
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
RenovoRx Announces Initial Results In Pharmacokinetic Substudy: Data On RenovoGem Supports Potential For RenovoTAMP Therapy Platform To Increase Local Gemcitabine Delivery And Decrease Side Effects Of Pancreatic Cancer Treatment
Researchers presenting four abstracts on different substudies, including the preliminary PK substudy, at the ASCO GI Cancers Symposium in San Francisco on January 19-21, 2023.
RenovoRx, Inc. (NASDAQ:RNXT), a
RenovoRx Granted U.S. Patent #11541211: Methods for delivery of therapeutic materials to treat cancer
https://www.scribd.com/document/617604795/RNRX-Patent
RenovoRx Announces Presentation At Symposium On Clinical Interventional Oncology Highlighting Its Innovative Therapy Platform For Targeted Treatment Of Pancreatic Cancer
RenovoRx, Inc. (NASDAQ:RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMPTM) therapy